GERON CORP GERON ORD SHS (0IV3.L) Financials
0IV3.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 413.0 million | 122.4 million |
2023-06-30 | 415.3 million | 116.9 million |
2023-03-31 | 424.9 million | 98.8 million |
2022-12-31 | 190.6 million | 110.6 million |
0IV3.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -51.0 million | 7.2 million |
2023-06-30 | -29.8 million | 3.9 million |
2023-03-31 | -46.7 million | 3.1 million |
2022-12-31 | -34.7 million | 2.3 million |
0IV3.L Net Income
No data available :(
0IV3.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 314.1 million | - | - |
2023-06-30 | 371.9 million | - | - |
2023-03-31 | 381.1 million | - | - |
2022-12-31 | 173.1 million | - | - |
0IV3.L Shares Outstanding
0IV3.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 192000 | 29.4 million | - | - |
2023-06-30 | 202000 | 35.5 million | - | - |
2023-03-31 | 372000 | 27.2 million | - | - |
2022-12-31 | 140000 | 28.2 million | - | - |
0IV3.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 164000 | - |
2023-06-30 | 29000 | 275000 |
2023-03-31 | 21000 | 251000 |
2022-12-31 | 103000 | 229000 |
0IV3.L
Price: $3.80
52 week price:
Earnings Per Share: -0.36 USD
P/E Ratio: -6.47
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 5.7 million